文献速递炎症性肠病肝病消化道肿瘤与早癌

肝移植与炎症性肠病合并原发性硬化性胆管炎患者结直肠异型增生风险降低相关

Liver Transplantation Is Associated With a Reduced Risk of Colorectal Dysplasia in Patients With IBD and Concomitant PSC.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-05-09

多机构回顾性队列研究比较320例接受肝移植与659例未接受肝移植的原发性硬化性胆管炎合并炎症性肠病(PSC-IBD)患者,随访期间239例(24%)发生结直肠肿瘤。多因素分析显示肝移植与结肠异型增生或癌症风险降低相关(OR 0.66,95%CI 0.47-0.93)。

要点

  • 肝移植与PSC-IBD患者结肠异型增生或癌症风险降低相关(OR 0.66,95%CI 0.47-0.93)。
  • 调整监测检查次数、染色内镜或内镜下活动性疾病后,结果不变。
  • 移植后复发PSC的患者异型增生更常见。

核心结论

  • 在本队列中,肝移植与PSC-IBD患者结肠癌/异型增生风险降低相关。

研究设计与样本

  • 多机构回顾性队列研究,比较320例接受肝移植的PSC-IBD患者与659例未接受肝移植的PSC-IBD对照。
  • 主要结局为平坦或可见的结肠癌、低级别异型增生或高级别异型增生的发生。
  • 采用多因素回归模型校正相关混杂因素,分析肝移植对癌症/异型增生发生的影响。

主要发现

  • 随访期间239例(24%)患者发生结直肠肿瘤。
  • 校正年龄、性别、研究地点、疾病病程和IBD类型后,肝移植与结肠异型增生或癌症风险降低相关(OR 0.66,95%CI 0.47-0.93)。
  • 进一步校正监测检查次数、染色内镜或内镜下活动性疾病后,结果不变。
  • 移植后发生复发性PSC的患者异型增生更常见。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary sclerosing cholangitis (PSC) affects up to 8% of patients with inflammatory bowel diseases (IBD) (Crohn's disease and ulcerative colitis) and is associated with an increased risk of colorectal neoplasia (CRN), which may be in part due to altered bile acid composition. About 40% of patients with PSC undergo liver transplantation. OBJECTIVE: The study sought to examine whether liver transplantation modifies risk of colorectal cancer in patients with PSC and IBD. METHODS: This was a multi-institution retrospective cohort study comparing colon dysplasia/cancer in patients with PSC-IBD who underwent a liver transplantation with those with PSC-IBD without a liver transplant. Our primary outcome was the development of flat or visible colon cancer, low-grade dysplasia, or high-grade dysplasia. Multivariable regression models adjusting for relevant confounders examined effect of liver transplantation on cancer/dysplasia occurrence. RESULTS: Our study cohort consisted of 320 patients with PSC-IBD with a liver transplant compared with 659 PSC-IBD control subjects without a liver transplant. Most (80%) had ulcerative colitis. During follow-up, 239 (24%) patients developed CRN. On multivariable analysis, adjusting for age, sex, study site, duration of disease, and type of IBD, liver transplantation was associated with a lower risk of colon dysplasia or cancer (odds ratio, 0.66; 95% confidence interval, 0.47-0.93). The findings were unchanged on adjusting for number of surveillance exams, chromoendoscopy, or presence of endoscopically active disease. Dysplasia was more common in patients who developed recurrent PSC after transplantation. CONCLUSIONS: Liver transplantation was associated with a reduced risk of colon cancer/dysplasia in patients with PSC-IBD in our cohort.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Coelho-Prabhu N, Ohri A, Benatzky C, et al. Liver Transplantation Is Associated With a Reduced Risk of Colorectal Dysplasia in Patients With IBD and Concomitant PSC. Clin Gastroenterol Hepatol. 2025. PMID: 40349894. doi:10.1016/j.cgh.2025.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。